It is encouraging to see these early results, which demonstrate the potential of our existing Injectable Aesthetics portfolio in addressing the effects of medication-driven weight loss on the skin, and were looking forward to presenting the nine-month data in due course. FLEMMING RNSKOV, M.D., mph CHIEF EXECUTIVE OFFICER GALDERMA Three-month interim data provide response to one of the most predominant aesthetic concerns of patients taking prescription weight loss medicines In a phase IV clinical trial conducted in the U.S., Galderma investigated the efficacy, safety, and patient satisfaction of Restylane Lyft or Contour in combination with Sculptra for cheek augmentation and correction of contour deficiencies in patients with medication-driven weight loss with associated facial volume loss
Activity: Combine resistance training and aerobic activity to reinforce metabolic adaptations and AMPK signalling [4]
These drugs improve glucose control, reduce weight, and lower cardiovascular risk
Warning - This product is not intended to cure or prevent any disease
Endocrinology (2004) 145(2):9941002
Draw the bacteriostatic water slowly until you reach your exact target volume
